WithdrawnNot Applicable

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa

Stopped: Study site was changed to another countr

Cameroon0Started 2022-09-01

Plain-language summary

This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in two different areas : Ngog-Mapubi and Bafia Health Districts (one area only endemic for onchocerciasis, and one area endemic for both loiasis and onchocerciasis).

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All voluntary adults Exclusion Criteria: * General acute infection (temperature ≥ 38,5°C) * Impaired general condition * Ivermectin taken in the 6 last months * Known allergies to one of the component of the patch * Dermatological acute infection (bacterial, atopic, prurigo, or zona)

What they're measuring

Tolerability of the patch

Timeframe: 24 hours

Feasibility of the patch

Timeframe: 24 hours

Trial details

NCT IDNCT04035174

SponsorCenter for Research on Filariasis and Other Tropical Diseases, Cameroon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-30

View on ClinicalTrials.gov More Onchocerciasis trials